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Abstract
Objective To determine the effectiveness of interventions designed to
improve outcomes in patients with multimorbidity in primary care and
community settings.
Design Systematic review.
Data sourcesMedline, Embase, CINAHL, CABHealth, Cochrane central
register of controlled trials, the database of abstracts of reviews of
effectiveness, and the Cochrane EPOC (effective practice and
organisation of care) register (searches updated in April 2011).
Eligibility criteria Randomised controlled trials, controlled clinical trials,
controlled before and after studies, and interrupted time series analyses
reporting on interventions to improve outcomes for people with
multimorbidity in primary care and community settings. Multimorbidity
was defined as two or more chronic conditions in the same individual.
Outcomes included any validated measure of physical or mental health
and psychosocial status, including quality of life outcomes, wellbeing,
and measures of disability or functional status. Also included were
measures of patient and provider behaviour, including drug adherence,
utilisation of health services, acceptability of services, and costs.
Data selection Two reviewers independently assessed studies for
eligibility, extracted data, and assessed study quality. As meta-analysis
of results was not possible owing to heterogeneity in participants and
interventions, a narrative synthesis of the results from the included
studies was carried out.
Results 10 studies examining a range of complex interventions totalling
3407 patients with multimorbidity were identified. All were randomised
controlled trials with a low risk of bias. Two studies described
interventions for patients with specific comorbidities. The remaining eight
studies focused on multimorbidity, generally in older patients.
Consideration of the impact of socioeconomic deprivation was minimal.
All studies involved complex interventions with multiple components. In
six of the 10 studies the predominant component was a change to the
organisation of care delivery, usually through case management or
enhanced multidisciplinary team work. In the remaining four studies,
intervention components were predominantly patient oriented. Overall
the results were mixed, with a trend towards improved prescribing and
drug adherence. The results indicated that it is difficult to improve
outcomes in this population but that interventions focusing on particular
risk factors in comorbid conditions or functional difficulties in
multimorbidity may be more effective. No economic analyses were
included, although the improvements in prescribing and risk factor
management in some studies could provide potentially important cost
savings.
Conclusions Evidence on the care of patients with multimorbidity is
limited, despite the prevalence of multimorbidity and its impact on patients
and healthcare systems. Interventions to date have had mixed effects,
although are likely to be more effective if targeted at risk factors or
specific functional difficulties. A need exists to clearly identify patients
with multimorbidity and to develop cost effective and specifically targeted
interventions that can improve health outcomes.
Introduction
Healthcare systems are placing increasing emphasis on the
management of chronic diseases. Despite the increasing numbers
of patients with two or more chronic conditions, or
multimorbidity, the delivery of care is usually built around single
diseases.1Awell established evidence base highlights the impact
and costs associated with multimorbidity in both younger and
older patients.2-6 Patients with multimorbidity are more likely
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to die prematurely than those with single conditions, be admitted
to hospital, and have longer hospital stays.6 7 They have poorer
quality of life, have loss of physical functioning, and are more
likely to experience depression and to be receiving multiple
drugs with consequent difficulties with adherence.8 9 Evidence
of the impact of socioeconomic deprivation is also clear as onset
of multimorbidity occurs 10-15 years earlier in people living in
the most deprived areas compared with those living in the least
deprived areas.10
Despite the increasing numbers of patients with multimorbidity,
evidence on the effectiveness of interventions to improve
outcomes in such patients is limited. The clinical care of these
patients is complex and the evidence base for managing chronic
conditions is based largely on trials of interventions for single
conditions, which too often exclude patients with
multimorbidity.11 12Clinical care is often fragmented, involving
both primary care and multiple secondary care specialists who
may not be communicating effectively, and there is a clear need
for integrated care of multiple conditions.13-16
We determined the effectiveness of interventions designed to
improve physical, psychosocial, and health service utilisation
outcomes in patients with multimorbidity in primary care and
community settings.
Methods
We used the methodology of the Cochrane collaboration. The
protocol and full review are available on the Cochrane Library.17
Inclusion criteria
The types of studies we considered eligible were randomised
controlled trials, controlled clinical trials, controlled before and
after studies, and interrupted time series analyses (meeting the
quality criteria of the Cochrane Effective Practice And
Organisation of Care Review Group). Studies published in all
languages were eligible for inclusion.
Participants included people or populations withmultimorbidity.
We adopted the most widely used definition of
multimorbidity—that is, the coexistence of multiple chronic
diseases and medical conditions in the same individual (usually
defined as two or more conditions).2 18 We used the World
Health Organization definition of chronic disease, which is
“health problems that require ongoingmanagement over a period
of years or decades.”19We included studies that only specifically
identified participants or subgroups of participants as having
multimorbidity.
We included any type of intervention that was specifically
directed towards a group of patients defined as having
multimorbidity. Interventions based only in primary care or
community settings were included andwe adopted the definition
of primary healthcare as providing “integrated, easy to access,
health care services by clinicians who are accountable for
addressing a large majority of personal health care needs,
developing a sustained and continuous relationship with patients,
and practicing in the context of family and community.”20 We
included care delivered in community settings by practitioners
fulfilling the basic criteria for primary care—that is, they are
available to treat all common conditions in all age groups and
have an ongoing relationship with their patients.
To group interventions for this review we used the taxonomy
of interventions developed by the Cochrane Effective Practice
And Organisation of Care Review Group (box).
Where interventions had multiple components we defined each
using the taxonomy and highlighted the predominant one of the
intervention for each study. We excluded professional
educational interventions or research initiatives where there was
no specified structured clinical care delivered to an identified
group of patients with multimorbidity and interventions targeted
at comorbid conditions where the intervention was targeted
solely at one of the conditions.
Outcome measures
We included validated outcomemeasures reporting on physical
health; patient reported measures reflecting psychological and
functional status , including wellbeing, quality of life, and
disability or pain; utilisation of health services, including
hospital admissions and visits to doctors; patient behaviour,
including diet and exercise and measures of drug adherence;
and provider behaviour, including prescribing.We also included
any available economic outcomes reported in included studies.
Search strategy
The search strategy was particularly challenging as
multimorbidity is a relatively new term and is sometimes used
synonymously with the term comorbidity, although this tends
to be used in relation to diseases that coexist with an index
condition. Comorbidity is aMeSH term, whereasmultimorbidity
is not, so we included both terms in our search. For pragmatic
reasons and because multimorbidity is a relatively new concept
we limited the Medline search to articles indexed from 1990
onwards.
We searched the following electronic databases: Medline,
Embase, CINAHL, CAB Health, the Cochrane central register
of controlled trials (CENTRAL), the database of abstracts of
reviews of effectiveness, AMED—Allied and Complimentary
Medicine (1985 to current), and the Cochrane EPOC (effective
practice and organisation of care) register (searches updated in
April 2011). We also searched reference lists of all included
papers and contacted the authors of relevant papers for any
further published or unpublished work (see the supplementary
file for the full Medline search strategy).
Data extraction
Potentially relevant studies were determined by review of the
abstracts of search results. We retrieved the full text copies of
all articles identified as potentially relevant. Two authors (SS
and HS) independently assessed each of these 30 retrieved
articles for inclusion, extracted data, and cross checked data
abstraction forms using a modified version of the Cochrane
Effective Practice And Organisation of Care data collection
checklist. The review authors resolved disagreements about
eligibility and quality by consensus.
Assessment of risk of bias
Two authors (SS and HS) independently assessed risk of bias
using standard Cochrane criteria, including sequence generation,
allocation concealment, blinding, protection against
contamination, reliability of primary outcomes, follow up of
patients, and performance of baseline measurement.
Data analysis
For each trial we calculated results in terms of absolute
difference (mean or proportion of outcome in intervention group
minus control at study completion) and relative percentage
difference (absolute difference divided by post-intervention
score in the control group). We contacted authors for missing
data. If studies were identified that were similar in terms of
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Taxonomy of interventions according to Cochrane Effective Practice And Organisation of Care Review Group
Professional interventions
For example, education designed to change the behaviour of clinicians
Organisational interventions
For example, any change to care delivery such as case management (defined as the “explicit allocation of co-ordination tasks to an appointed
individual or group”)21, or the addition of different healthcare workers, such as a pharmacist, to the healthcare team
Patient oriented interventions
For example, patient education or support for self management
Financial interventions
For example, financial incentives to providers to reach treatment targets
Regulatory interventions
For example, changes to local or national regulations designed to alter care delivery to improve outcomes
settings, patients, interventions, outcome assessment, and study
methods we planned to carry out meta-analysis. This was not,
however, possible owing to noticeable clinical heterogeneity.
We therefore carried out a narrative synthesis of the results from
the included studies.
Results
Figure 1⇓ outlines the search. Overall, 20 177 potentially eligible
titles were identified.
Overall, 17 of 30 full text articles screened for eligibility were
excluded on the basis of study design and intervention type.
Three ongoing studies led to the identification of 10 studies
included in the narrative synthesis. All 10 were randomised
controlled trials, totalling 3407 patients (table 1⇓) The studies
varied in duration from eight weeks to two years, with most
lasting 6-12 months. Eight of the 10 studies included patients
with a broad range of conditions,22-29whereas the remaining two
focused on comorbidities: coexisting depression and
hypertension30 and coexisting depression and diabetes or heart
disease.31 Most were based in the United States, apart from one
study set in the United Kingdom27 and one in Canada.26All were
funded by a government or university grant or charitable
foundation.
Inmost of the included studies the comparator was usual medical
care, which was supplemented by a newsletter or leaflet23 24 or
assessment but no follow-on intervention.27 30 31 One study used
an attention control based on an unrelated topic, with control
patients also attending a group session.25 No study specifically
reported patient or family involvement in the intervention
design.Whereas only two of the six organisational studies were
based on explicit theoretical frameworks, all four of the patient
oriented interventions were guided by a variety of frameworks
(table 1). In the four organisational studies that did not specify
a theoretical framework, the intervention was presented as
enhancing multidisciplinary teamwork. Only one of the 10
studies specifically targeted disadvantaged patients or those on
low incomes.23 Socioeconomic status was recorded at baseline
in three of the remaining studies, but no study considered a
differential effect of the intervention based on socioeconomic
status of participants.
Description of interventions
The interventions were all multifaceted (table 1). Although the
interventions identified all multiple components they could be
divided into two main groups: predominantly
organisational22 26 27 29-31 and predominantly patient oriented.23-25 28
No study involved financial incentives or regulatory
interventions. Table 2⇓ outlines the elements of the interventions
in the included studies.
Risk of bias in included studies
Overall the studies had low risk of bias (fig 2⇓). Baseline
measurement, use of reliable outcomes, and follow-up of
participants was done inmost studies. Randomisation, allocation
concealment, and blinding of outcome assessment was less
reliably reported or carried out. Only two of the 10 studies had
a cluster design ensuring no contamination of control
patients.22 29 The patient oriented interventions were less likely
to result in contamination of control patients as the intervention
was not delivered through healthcare providers. The two cluster
randomised controlled trials had accounted for design effects
in their analysis, with no unit of analysis errors.22 29
Effects by type of intervention
As interventions could be classified generally as organisational
or patient oriented, results are presented in these groupings. It
must be stressed that all interventions were complex and
multifaceted, with overlapping components across these two
classifications. No study attempted to link outcomes to specific
intervention components.
Six studies had organisational interventions.22 26 27 29-31 These
predominantly involved case management and coordination of
care or the enhancement of skill mix in multidisciplinary teams.
Overall the results indicated that organisational interventions
targeted at specific risk factor management or that focused on
areas where patients have difficulties, such as with the
management of medicines, were more likely to be effective.
Organisational interventions with a broader focus, such as case
management or changes in delivery of care, seemed less
effective.
Four studies had predominantly patient oriented
interventions.23-25 28 All aimed to deal with patient health related
behaviour and did not engage or intervene with healthcare
providers directly. In general, patient oriented interventions not
linked to healthcare delivery seemed less effective, although
the exception was a professional led patient oriented intervention
focused on functional difficulties, which was associated with
significant improvements including a reduction in mortality in
the intervention group.24 32
Physical health outcomes
Four of the six studies with organisational interventions reported
physical health outcomes. Two of these reported statistically
significant improvements in blood pressure.30 31 One also
reported statistically significant improvements in glycated
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haemoglobin and low density lipoprotein cholesterol levels and
in their composite primary outcome, which included these three
physical health outcomes and a depression score.31
Two studies with patient oriented interventions reported physical
health outcomes. One of these reported mixed results for three
outcomes, with significant improvements in dietary behaviour
and support for healthy lifestyle but no improvement in physical
activity.23 The other reported a follow-up study, which found
significantly reduced mortality in the first two years after a
focused occupational therapy and physiotherapy led intervention
targeting functional difficulty and fall prevention (table 1)
Mental health outcomes
Three organisational studies presented data on mental health
outcomes.29-31 Two of these showed significant improvements
in depression related outcomes.30 31 One of the four patient
oriented studies presented data on mental health outcomes and
found no difference in the management of cognitive symptoms
between groups at study completion.28
Patient reported functional health outcomes
Four organisational type studies involved patient reported
functional health outcomes.26 27 29 31 One found significant
improvements,31 whereas another found significant
improvements in social activities but no significant differences
in scores on the short form 36 health survey (SF-36) or health
assessment questionnaire.29 All four of the patient oriented
studies reported a range of these outcomes (table 1) but only
one reported improvements, which occurred in two of the six
psychosocial outcomes reported.24
Utilisation of health services
Five of the six organisational studies reported outcomes on
utilisation of health services.22 26 27 29 31Only one of these reported
significant improvements across a variety of measures related
to hospital admissions, although numbers of admissions were
small in most studies. Three studies reported on visits to a range
of health service providers and none showed significant changes
in health service use.22 26 29 One of the four patient oriented
studies reported outcomes on health services utilisation and
found significant improvements across a variety of measures
related to hospital admissions.28
Patient behaviour
Only one organisational study reported measures relating to
drug use and adherence and found significant improvements in
proportions of intervention patients adhering to both
antidepressants and antihypertensives, as measured using
automated counting systems in the caps of medicine bottles
(MEMS caps).30 Two organisational studies provided data on a
variety of outcomes related to health behaviours by patients and
found no significant improvement.29 31 Two patient oriented
studies also reported on patient health behaviours,23 28 although
only one reported significant improvements in diet behaviour
scores and in minutes of walking per week.23
Provider behaviour
Two organisational studies reported measures relating to
prescribing by practitioners or the management of medicines,
both of which indicated significant benefits for intervention
patients. One study reported drug adjustments for five classes
of drugs related to the comorbid conditions being studied and
found statistically significant differences for four of these five
groups.31 The other study reported a significant reduction in
pharmaceutical care issues in intervention patients, which would
have resulted from changes in both intervention by pharmacists
and prescribing by general practitioners.27
Two other organisational studies reported on the behaviours of
providers related to the management of chronic disease or
preventive care.22 26 The guided care study included a secondary
outcome of a validated patient measure called the patient
assessment of chronic illness care (PACIC) score.22 The
aggregate quality score was significantly improved. The other
study reportedmeasures relating to chronic disease management
and preventive care based on data from charts.26Both outcomes
were significantly improved in the intervention group (table 1).
Acceptability of services
Only two organisational studies reported satisfaction with
treatment as secondary outcomes. One study reported that
significantly more intervention patients were satisfied with their
care at study completion compared with those experiencing
usual care.31 The other study reported on the changes in
satisfaction for providers as part of an overall examination of
the effect of the intervention on providers.22 Five of the 11
domains relating to satisfaction with service provision did not
improve significantly.22
Costs
Four organisational studies provided data on costs.22 27 29 31 These
data were difficult to compare across the studies and were often
presented in relation to non-significant results, indicating that
no study had identified a significantly cost effective intervention.
Two patient oriented studies provided data on direct costs of
providing the intervention.24 28One calculated that the reduction
in hospital admissions led to a saving in healthcare costs per
participant of $750 (£478; €611), which was 10 times the cost
of the intervention.
Comorbidity versus multimorbidity studies
Two of the 10 included studies focused on comorbidity rather
than on multimorbidity in general.30 31 Both of these studies had
organisational type interventions and were able to use more
disease focused interventions and outcome measures. Both
showed more significant intervention effects than the
multimorbidity studies.
Discussion
Multimorbidity presents an important clinical and organisational
challenge to the current single system approach to the
management of chronic disease. In this review we identified 10
relatively recent randomised trials (up to April 2011). Even
within this small number of studies the variation in participants
and interventions was substantial and a variety of theoretical
frameworks was applied. In two studies the focus was on
comorbid conditions, whereby the interventions were directed
at prespecified conditions. In the other studies, which included
patients with any combination of conditions, the focus tended
to be on older patients and the interventions had multiple
components, making comparison between studies and between
intervention components difficult. Overall these studies suggest
that organisational interventions targeted at the management of
specific risk factors or focused on areas where patients have
difficulties, such as with functional ability or the management
of medicines, seem more likely to be effective. Organisational
interventions that have a broader focus, such as case
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management or changes in delivery of care, seem less effective.
The patient oriented interventions that were not linked to
healthcare delivery or specific functional difficulties were also
less effective.
In general the results were mixed and inconclusive, particularly
those relating to physical health outcomes. The lack of focus
on physical healthmeasuresmay reflect the challenge in research
on multimorbidity, as disease specific clinical outcomes cannot
be used. Three studies measured outcomes relating to
prescribing, use of drugs, and drug adherence and all found
significant benefits. The studies, however, may be too short for
these benefits to translate into improvements in physical health
outcomes. Costs were presented in six studies but data were
only provided on direct costs. The results relating to improved
prescribing and risk factor management, particularly in the
comorbidity trials, indicate a potential for these interventions
to reduce health service costs over longer periods.
Unsurprisingly most of the studies in this reviewwere relatively
recent, as research on multimorbidity is a conceptually new area
and to date has focused on description and impact rather than
on interventions. Earlier studies tended to focus on comorbidity
rather than multimorbidity. The improvements found in studies
with a focus on comorbid conditions are likely to be related to
the strong focus in these interventions of targeting specific
conditions. Although it is more challenging to design
interventions for people with a broad range of conditions,
interventions that seemed more effective in this group were
those that targeted specific areas of concern for patients. One
of the more recent included studies was a large well designed
and executed randomised trial of a broad organisational
intervention, the “guided care” model, targeted at high risk
people with multimorbidity, but which found no significant
benefit overall.22 However, a preplanned subgroup analysis
within this trial indicated significant improvements in the use
of some health services in the patients enrolled in one of the
participating care plans (Kaiser-Permanente, n=365, 43% of
full sample). This difference highlights the importance of the
healthcare delivery setting into which new interventions are
added. Indeed, some of the patient oriented interventions were
delivered independently of patients’ healthcare, and most of
these studies had limited effectiveness, suggesting that
interventions should be integrated into the healthcare system.
The results of the patient oriented intervention studies were
consistent with those of the Cochrane review on lay led self
management support programmes, which found no evidence
that these interventions improve psychological health,
symptoms, or health related quality of life, or that they
significantly alter healthcare use.33
Strengths and weaknesses of this review
To our knowledge this is the first systematic review of
interventions for patients with multimorbidity. Potential
limitations in the search process related to the lack of a MeSH
term for multimorbidity.We therefore used broad search terms,
which led to a high yield of citations to be searched and a need
to limit theMedline search to 1990 onwards. The review authors
are, however, active researchers in the discipline of
multimorbidity and we are unaware of any potentially eligible
studies missed by the search. We were also unable to retrieve
missing data from some authors. As no meta-analysis was
undertaken this did not lead to any appreciable bias. We were
unable to group sufficient numbers of studies with similar
interventions to comment on which elements of interventions
(for example, the use of community pharmacists) seemed most
effective and to compare our review to other reviews of these
interventions.
Implications for clinical practice and future
research
Multimorbidity is common in clinical practice, and evidence
supporting specific interventions is limited. Most of the studies
in this review focused on older patients; however, it is also
important to deal with the needs of younger patients with
multimorbidity, which are likely to be different and to include
problems related to employment and absenteeism.34 Absolute
numbers of patients with multimorbidity are higher in those
aged less than 65 years,10 and a recent systematic review on
prevalence studies on multimorbidity reported a low prevalence
before age 40 followed by a steep increase and a plateau after
age 70. This would suggest that interventions should target
patients across the age spectrum.35 There was minimal
consideration of the impact of socioeconomic deprivation in
the included studies, and no study considered the possibility of
a differential effect of interventions in different socioeconomic
groups. Research in Scotland has found that people in the
poorest socioeconomic groups are more likely to develop
multimorbidity at a younger age and to have greater mental
health problems compounding difficulties in their management.10
Research onmultimorbidity would be facilitated by the inclusion
of multimorbidity as aMeSH term. Otherwise, related literature
searches are particularly complex and time consuming. An
additional challenge for researchers is to define a set of generic
outcome measures that incorporate physical functioning and
quality of life and that are responsive to change over time. The
recent work of PROMIS (patient reported outcomes
measurement information system) provides validated and useful
patient reported outcomes that will be particularly relevant for
those researching interventions to improve outcomes for patients
with multimorbidity.36
Future research should be planned in collaboration with policy
makers to ensure applicability and successful integration of
interventions into current delivery systems. Studies must include
clear conceptual definitions of multimorbidity and the
differentiation of multimorbidity from other related concepts
such as comorbidity, complexity, frailty, and vulnerability.
Without these definitions and consideration of related theoretical
concepts, the generalisability or applicability of studies for
patients with multimorbidity (with a broader definition than
only two or three diseases) will be uncertain, as is the case for
many of the studies in this review, particularly those with a
specific focus on comorbidity.
The review has highlighted the lack of a clear theoretical
framework guiding interventions for multimorbidity at present.
There is still a need for prospective cohort studies that will give
more information on the trajectory of patients with
multimorbidity across all ages and socioeconomic groups.37
Researchers in this area need to collaborate and develop
consensus on which models are likely to be most appropriate
for multimorbidity. Once identified, authors who develop
interventions should consider the individual components of the
interventions and the evidence base behind each and link these
to relevant outcomes, including health economic analyses.
Conclusion
This review highlights the paucity of research into interventions
to improve outcomes for patients with multimorbidity, with the
focus to date being on comorbid conditions or multimorbidity
in older patients. The review indicates that interventions targeted
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either at specific combinations of common conditions or at
specific problems for patients with multiple conditions, may be
more effective. Further research is, however, needed and future
interventions should be developed in ways that allow rigorous
evaluations that will add to the evidence. There is a need for
clear and broader definitions of participants, consideration of
appropriate outcomes, and further pragmatic studies based in
primary care settings.
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What is already known on this topic
Patients with multimorbidity have poorer health outcomes than those with single chronic conditions
Despite the increasing numbers of patients with multimorbidity, the delivery of care is usually built around single diseases
Existing evidence on the effectiveness of interventions to improve outcomes in patients with multimorbidity is limited
What this study adds
This review identified 10 randomised trials, highlighting the paucity of research into interventions to improve outcomes for patients with
multimorbidity
The focus to date has been on comorbid conditions or multimorbidity in older patients
The review indicates that interventions targeted either at specific combinations of common conditions or at specific problems for patients
with multiple conditions, may be more effective
Tables
Table 1| Characteristics of studies included in systematic reviews
Results (primary outcomes, where
specified): intervention versus
control
OutcomesIntervention elements;
(theoretical framework, where
specified)
Duration and
follow-up
Study participantsStudy
Predominantly
organisational
interventions:
CES-D score 9.9 v 19.3, P=0.006;
systolic blood pressure (mm Hg) 127.3
v 141.3, P=0.003; ≥80% adherence to
antidepressants 23% v 10%, P=0.001,
≥80% adherence to antihypertensives
25% v 10%, P<0.001
Depression scores (CES-D
score); systolic blood pressure;
drug adherence
Care manager, structured visits,
telephone contact, and patient
care plans (adherence based
model)
Intervention six
weeks, follow-up
two weeks later
Aged >50,
depression and
hypertension (n=64)
Bognor
200830
Adjusted intervention:control ratio of
service use: hospital 30 day
readmissions 1.01 (95% CI 0.83 to
1.23); hospital days 0.79 (0.53 to 1.16);
skilled nursing facility admissions 1.00
(0.77 to 1.30); skilled nursing facilities
Primary outcome: health
service use hospital
admissions, nursing facility use,
visits, and home healthcare
episodes. Secondary outcomes:
quality of chronic care (PACIC)
scores
Organisational: guided care
nurse managers, enhanced
multidisciplinary team, home
assessments and monthly
monitoring, patient care plans.
Professional: education of nurse
managers. Patient: self
management support
Intervention 18
months, follow-up
at six and 18
months
Aged >65, multiple
conditions and high
service use (n=904)
Boult 201122
days 0.92 (0.6 to 1.4); emergency
department visits 0.84 (0.48 to 1.47);
primary care visits 1.04 (0.81 to 1.34);
speciality care visits 1.02 (0.91 to 1.14);
home healthcare episodes 1.07 (0.93
to 1.23); (PACIC) scores 0.70 (0.53 to
0.93)
Difference in chronic disease
management score after intervention
0.091 (95% CI 0.037 to 0.144)
Primary outcome: chronic
disease management score.
Secondary outcomes included
preventive care delivery score,
physical health outcomes,
health service use,
Enhancedmultidisciplinary team
with structured home visit, drug
review, and patient care plans
Intervention 15
months, follow-up
on completion of
intervention
Aged >50, at least
two conditions and
at risk of
experiencing
adverse outcome
(n=241)
Hogg 200826
psychosocial measures, quality
of life, and activities of daily
living
Adjusted between group difference
(95% CI): depression scores SCL-20)
−0.41 (−0.56 to −0.26); glycated
haemoglobin −0.56% (−0.85% to
−0.27%); systolic blood pressure (mm
Hg) −3.4 (−6.9 to 0.1); low density
Primary outcomes: depression
scores (SCL-20); diabetes
(glycated haemoglobin); systolic
blood pressure; and low density
lipoprotein cholesterol.
Secondary outcomes: increases
Organisational: TEAMcare
nurses, structured visits, patient
care plans and treatment targets,
weekly team meetings, and use
of electronic registry to track
patient progress. Professional:
Intervention 12
months, follow-up
at 12 months
Depression and
diabetes or coronary
heart disease, or
both (n=214)
Katon 201031
lipoprotein cholesterol (mg/dL) −9.1
(−17.5 to −0.8)
in drug adjustments, quality of
life, and satisfaction with care
education of nurse managers.
Patient: support for self care
(behavioural activation theory)
Pharmaceutical care issues (%)
resolved after intervention: 82.7% v
41.2%, P<0.001
Primary outcome:
pharmaceutical care issues.
Secondary outcomes: medicine
costs, quality of life, and health
service use
Senior care connections:
structured visit with
pharmaceutical patient care plan
created by pharmacist and
implemented by practice team
Intervention three
months, follow-up
three months after
drug review
Aged >65, at least
two conditions
(n=332)
Krska 200127
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Table 1 (continued)
Results (primary outcomes, where
specified): intervention versus
control
OutcomesIntervention elements;
(theoretical framework, where
specified)
Duration and
follow-up
Study participantsStudy
Odds ratio admissions/patient/year 0.63
(95% CI 0.41 to 0.96); ≥1 60 day
Health service use including
admissions, office visits,
Organisational: enhanced
multidisciplinary team including
Intervention two
years, follow-up 12
Aged >65, at least
two conditions
(n=543)
Sommers
200029
readmissions 0.26 (0.08 to 0.84). Notemergency department visits,social worker, homemonths after
intervention fully reported for seven other outcomes,home care visits, and nursingassessment, and patient care
non-significant for six. Difference inhome visits. Patient reportedplans, professional: training of
care coordinators adjusted mean scores, social activitieshealth status: social activities
count 0.50 (95% CI 0.02 to 1.00).count, quality of life, depression
Symptom scale 0.50 (−3.20 to 0.16),scores, nutrition checklists, and
drug adherence SF-36 self rated health 0.10 (−0.27 to
0.02), not reported for four other
outcomes, non-significant
Predominantly
patient
oriented:
Adjusted mean (SE): dietary behaviour
(lower score better) 2.20 (0.05) v 2.41
(0.05), P<0.5; support for healthy
lifestyle (higher score better) 2.98 (0.06)
v 2.68 (0.06), P<0.05; change minutes
walking/week 8 (22) v −10 (27), P>0.5
Dietary behaviour, support for
healthy lifestyles, and physical
activity
Patient: self management
support, diet, and exercise
intervention delivered by health
educator; organisational:
structured visits and telephone
contact (chronic care model:
patient self management)
Intervention 16
weeks, follow-up
six months after
intervention
Multimorbidity
defined as at least
two conditions
(n=175) (data for
multimorbidity group
from authors)
Eakin 200723
Difference in adjusted means at 12
months: activities of daily living −0.10
(95% CI −0.21 to 0.02); instrumental
activities of daily living −0.12 (−0.26 to
0.03); mobility −0.14 (−0.29 to 0.01);
overall self efficacy 0.09 (−0.06 to 0.23);
Primary outcomes: functional
difficulty (activities of daily
living, activities of daily living,
instrumental activities of daily
living, and mobility), self
efficacy and fear of falling (self
Patient (Advancing Better Living
for Elders, ABLE): occupational
therapy and physiotherapy home
based intervention including
balance and muscle
strengthening and fall recovery
12 months
intervention,
follow-up at
completion of
intervention, four
year mortality
follow-up
Aged >70, multiple
conditions and
reported difficulties
with activities of
daily living (n=319)
Gitlin 200624
32
fear of falling 0.56 (0.15 to 0.97);efficacy for falls). Secondarytechniques, patient: problem
mortality at two years 5.6% (9 deaths)outcomes: adaptive strategysolving techniques (lifespan
theory of control) v 13.2% (21 deaths), P=0.02. Mortalityuse and presence of home
at four years no significant difference,hazards. Four year follow-up:
mortality intervention increased survivorship by
3.5 years
Patient activation measure: reported as
no significant difference between
intervention and control at follow-up
Primary outcome: patient
activationmeasure. Secondary
outcomes: total unhealthy days,
self efficacy, and self rated
health
Patient engagement intervention
led by “coaches” with focus on
making most of healthcare
(chronic care model: patient self
management)
Intervention three
months, follow-up
three months after
intervention
Aged >65, at least
two of seven chronic
conditions (n=79)
Hochhalter
201025
Adjustedmean difference (SD). Number
of admissions 0.19 (0.73) v 0.33 (1.2),
P<0.5; nights in hospital 1.05 (6.3) v 2.1
(6.8), P<0.5; number of physician visits
4.96 (6.1) v 6.87 (7.2), P>0.5.
Significance of 12 measures relating to
Health service use: admissions,
emergency department plus
visits to physician. Health
behaviours: four measures.
Health status: eight measures
Patient (weekly community
based meetings led by trained
volunteer lay leaders focusing
on self management and peer
support) (Bandura’s self efficacy
theory)
Intervention seven
weeks, follow-up at
six months
Aged >40, at least
two of heart
disease, lung
disease, arthritis, or
stroke (n=536)
(subgroup of
Lorig 199928
health behaviours and health status in
comorbidity subgroup not reported
patients with
comorbidities)
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Table 2| Intervention elements in included studies
StudiesIntervention element
Professional
Boult22, Katon31, Sommers29Education or training of care coordinators
Financial
Patient
Eakin23*, Boult, Katon, Lorig28*, Hochhalter25*Self management support and patient education
LorigPeer support
Organisational
Provider:
Bognor30*, Boult*, Katon*, Sommers29Care coordination or management
Hogg26*, Katon, Krska27*, Sommers*Enhanced multidisciplinary team (for example, addition of pharmacist or social worker)
Patient:
Bognor, Boult, Hogg, Katon, Krska, SommersIndividual care plans
Structural:
Eakin, Bognor, Boult, Hogg, Katon, KrskaStructured visits
Bognor, Eakin, Hochhalter, HoggStructured telephone contact
Regulatory†
*No studies reported on this element.
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Figures
Fig 1 Study flow of papers through review
Fig 2 Risk of bias in included studies
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